Your browser doesn't support javascript.
loading
Predictive value of next-generation sequencing-based minimal residual disease after CAR-T cell therapy.
Huang, Yue; Zhao, Houli; Shao, Mi; Zhou, Linghui; Li, Xiaoqing; Wei, Guoqing; Wu, Wenjun; Cui, Jiazhen; Chang, Alex H; Sun, Tao; Hu, Yongxian; Huang, He.
Afiliación
  • Huang Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhao H; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.
  • Shao M; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Zhou L; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Li X; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Wei G; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.
  • Wu W; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Cui J; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
  • Chang AH; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Sun T; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.
  • Hu Y; Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Huang H; Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.
Bone Marrow Transplant ; 57(8): 1350-1353, 2022 08.
Article en En | MEDLINE | ID: mdl-35650329

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: China